Ascentage Pharma Group In... (AAPG)

NasdaqGM: AAPG · 실시간 가격 · USD

18.44

+1.54 (9.11%)

종가 기준: Aug 27, 2026, 8:00 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

9.11% (1D)

데이터 없음

매수호가	18.19
시가총액	1.75B
매출 (ttm)	642.64M
순이익 (ttm)	-1.47B
	0.67
	-2.35
	n/a
	-13.9
P/B (ttm)	21.09
P/S (ttm)	2.72
실적 발표일	Aug 7, 2025

매도호가	23.14
거래량	14,308
평균 거래량 (20일)	11,007
시가	18.42
전일 종가	16.90
일중 범위	18.26 - 18.71
52주 범위	16.36 - 42.48
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

AAPG 소개

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; A...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Jan 24, 2025

직원 수 828

상장 거래소 NasdaqGM

티커 AAPG

웹사이트 https://www.ascentage.cn

전체 기업 정보

재무 실적

2025년 Ascentage Pharma Internat의 매출은 574.12M로, 전년 980.65M 대비 -41.46% 감소했습니다. 순이익은 -1.24B로, 206.53% 증가했습니다.

재무제표

다음 실적 발표

Ascentage Pharma Group Internat의 실적 발표 예정일은 Aug 7, 2025, 장 시작 전입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

1주 전 · Moby

ASCENTAGE PHARMA GROUP INTERNATIONAL Q2 2026 Earnings Call Summary

Moby summary of ASCENTAGE PHARMA GROUP INTERNATIONAL's Q2 2026 earnings call

1주 전 · MarketBeat

Ascentage Pharma Group International H1 Earnings Call Highlights

Ascentage Pharma Group International (NASDAQ:AAPG) reported first-half 2026 revenue growth as it continued investing in global registrational studies for its hematology-oncology pipeline and began bui...

1개월 전 · Zacks

Wall Street Analysts Predict a 160.09% Upside in Ascentage Pharma Group International - Unsponsored ADR (AAPG): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 160.1% in Ascentage Pharma Group International - Unsponsored ADR (AAPG). While the effectiveness of this highly...

1개월 전 · Zacks

How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Street Analysts Think 152.23%

The consensus price target hints at a 152.2% upside potential for Ascentage Pharma Group International - Unsponsored ADR (AAPG). While empirical research shows that this sought-after metric is hardly ...

1개월 전 · Insider Monkey

Why Ascentage Pharma Group Internat (AAPG) Is Gaining Attention in Cancer Drug Development

We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Ascentage Pharma Group Internat (NASDAQ:AAPG) is one of the best biotech stocks on this list. TheFly reported on...

2 페이지 중 1

Ascentage Pharma Group In... (AAPG)

AAPG 소개

재무 실적